SERIAL SAMPLING OF MIDREGION PROADRENOMEDULLIN IS PREDICTIVE OF SHORT TERM MORTALITY IN PATIENTS ADMITTED FOR SHORTNESS OF BREATH

Background: Midregion proadrenomedullin (MR-proADM) was shown to predict 90-day mortality in shortness of breath in the BACH (Biomarkers in Acute Heart Failure) study.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A986-A986
Main Authors: Phreaner, Nicholas, Peacock, W. Frank, Anker, Stefan, Maisel, Alan
Format: Article
Language:English
Subjects:
Biomarkers
Cardiology
Cardiovascular
Heart failure
Internal Medicine
Medical research
Mortality
Short term
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Midregion proadrenomedullin (MR-proADM) was shown to predict 90-day mortality in shortness of breath in the BACH (Biomarkers in Acute Heart Failure) study.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)60986-X